The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer

The approval of targeted therapies for metastatic colorectal cancer (mCRC) has led to important improvements in patient outcomes. However, it is still necessary to increase individualisation of treatments based on tumour genetic profiles to optimise efficacy, while minimising toxicity. As such, ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Taieb, Julien, Jung, Andreas, Sartore-Bianchi, Andrea, Peeters, Marc, Seligmann, Jenny, Zaanan, Aziz, Burdon, Peter, Montagut, Clara, Laurent-Puig, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728290/
https://www.ncbi.nlm.nih.gov/pubmed/31347092
http://dx.doi.org/10.1007/s40265-019-01165-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728290/
https://www.ncbi.nlm.nih.gov/pubmed/31347092
http://dx.doi.org/10.1007/s40265-019-01165-2

Ejemplares similares